Log in to save to my catalogue

i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations

i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c8c503ef40b04102b7fbc348c1cb9d7a

i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations

About this item

Full title

i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations

Publisher

London: BioMed Central Ltd

Journal title

Molecular cancer, 2022-08, Vol.21 (1), p.1-164, Article 164

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Developing a strategy to specifically kill cancer cells without inducing obvious damage to normal cells may be of great clinical significance for cancer treatment. In the present study, we developed a new precise personalized strategy named "i-CRISPR" for cancer treatment through adding DNA damage repair inhibitors(i) and inducing cancer cell-speci...

Alternative Titles

Full title

i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c8c503ef40b04102b7fbc348c1cb9d7a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c8c503ef40b04102b7fbc348c1cb9d7a

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-022-01612-x

How to access this item